» Authors » Carlo S Legasto

Carlo S Legasto

Explore the profile of Carlo S Legasto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 14
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Alhaja M, Chen S, Chin A, Schulte B, Legasto C
Cureus . 2023 Oct; 15(9):e44837. PMID: 37809186
Background: Lifetime cumulative doses of conventional doxorubicin (>450 mg/m2) are associated with dose-dependent cardiotoxicity. In sarcoma and breast cancer, conventional doxorubicin is often utilized in the adjuvant setting, whereas pegylated...
2.
Guan T, Laguna A, Soares A, Legasto C, Block S, Saunders I, et al.
J Thromb Thrombolysis . 2023 Jul; 56(3):439-446. PMID: 37421494
Background: Direct oral anticoagulant (DOAC) use in cancer-associated venous thromboembolism (CA-VTE) has increased due to updates in recent guidelines and literature. However, select guidelines caution against DOAC use in patients...
3.
Freeman T, Legasto C, Schickli M, McLaughlin E, Giglio P, Puduvalli V, et al.
Neurooncol Adv . 2020 Jul; 2(1):vdaa077. PMID: 32715297
Background: Primary central nervous system lymphoma (PCNSL) is a rare malignancy with few treatment options. One regimen used for induction is rituximab, high-dose methotrexate (HD-MTX), procarbazine, and vincristine (R-MPV). A...
4.
Pisano S, Hoffman S, Legasto C, McLaughlin E, Porter K, Chen J
Clin Transl Sci . 2019 Jul; 12(5):529-533. PMID: 31264782
Pazopanib (PAZ), a tyrosine kinase inhibitor used in the treatment of soft tissue sarcoma (STS), should not be administered with acid-suppressive medications (ASMs) due to decreased drug solubility. Common practice...
5.
Burgess H, Legasto C, Fogg L, Smith M
Appl Ergon . 2012 Jun; 44(1):109-11. PMID: 22695081
Small shifts in circadian timing occur frequently as a result of daylight saving time or later weekend sleep. These subtle shifts in circadian phase have been shown to influence subjective...